The interaction between amyloid peptides and membrane is a broad research topic due to the variety of biological events occurring, such as the membrane disruption related pathogenesis of amyloid diseases or the toxicity of peptide materials. Amyloid peptides have many structural forms, it is therefore important to explore the interactions between the membrane and assemblies of amyloid peptides, and to find ways to control these interactions. Herein, we utilized atomic force microscopy (AFM) and circular dichroism spectra to explore the modulating effect of Graphene Oxide (GO) on amyloid peptide assembly. In addition, the interaction between liposome samples and amyloid peptide assembly modulated by GO was investigated. It is achieved that the membrane disruption of amyloid peptide aggregates can be fine-tuned by tweaking the GO concentration. The findings in this work provide a better understanding of amyloid peptide and membrane interactions and how it can be tuned.
Introduction
Biophysical explorations and mechanistic researches with simplified model membrane systems could contribute to the fundamental understanding of the interactions between amyloid-forming proteins and membranes 1 . Amyloid peptides can assemble into different ordered or disordered forms such as pores, fibers and aggregates. In intermediate stages, it is often possible to see a mixture of different forms. With its changing structure, the peptides' toxicity and role in pathogenesis also changes. Therefore, it is of utmost importance to study the stages of morphological transformation and how it can be controlled.
Beta amyloid peptide (Aβ) is a typical amyloid peptide derived from the amyloid precursor protein (APP) by proteolysis 5 . The fragments of Aβ 6 for instance, Aβ28 7 ,
Aβ25-35 8 and Aβ10-20 9 , form aggregates that were proved to have the ability to interact with the membrane. Recently Aβ33-42 as a significant fragment of the transmembrane domain of APP was considered to be able to target the cell membrane 10, 11 and it is also a key fragment 12 of Aβ42, dominating its aggregation. It is therefore a good candidate to be explored for the assembling mechanism, modulating the mechanism of assembled structure and the interaction with liposome. Many efforts have been made to explore the modulation of the formation of amyloid aggregates 13 .
Many agents have been introduced for the modulation of amyloid peptide assembly 13, 14 . Recently, it has been reported that carbon nanotubes and fullerenes have strong inhibitory effect on amyloid aggregation [15] [16] [17] [18] [19] . As a promising and emerging carbon nanomaterial, graphene has also received much attention.
Importantly, it provides opportunities for biological applications such as drug delivery [20] [21] [22] , tissue engineering 23, 24 , and a promising platform for the development of biosensors [25] [26] [27] [28] [29] [30] [31] . Furthermore, intrinsic graphene is lipophilic. Chemical modified graphene can tune the hydrophilic and lipophilic properties of graphene to control the interactions with biological membranes [32] [33] [34] . Therefore, considering the improvement of solubility, biocompatibility and selectivity of GO, provides the possibility to modulate the assembled nanostructure of amyloid peptides because GO is considered to have good affinity to bind peptides 39 . The recent experimental and simulation studies have presented that GO can modulate the amyloid peptide fibrillation in solution [35] [36] [37] [38] [39] . Therefore, it is implied that GO are significant nanomaterials for tuning amyloid peptide aggregation.
Atomic force microscopy (AFM) is capable of obtaining nanoscale resolution of individual molecules or supermolecular structures. This method also allows for the investigation of the self-assembly mechanism and the driving forces of aggregation [40] [41] [42] [43] [44] . Furthermore, AFM provides the possibility to follow the dynamics to obtain a detailed picture of the amyloid assembly process 45 , and the interaction between the liposome and peptides.
In this study, we acquired images of plain GO. We then imaged its mixture with amyloid peptide. Formed assemblies and their varying morphologies were revealed using AFM. We continued AFM investigation by tuning the GO concentration which, as proposed, resulted in alteration of the structure and activity of amyloid peptide assemblies. To further our understanding of amyloid peptides structural change we conducted circular dichroism experiments. Our results indicate that it is possible to change the structure of amyloid peptide assemblies by modulating it with GO. To this end, we formed liposome particles and measured the membrane disruption of amyloid peptide assemblies with and without GO modulation. We interpreted the morphological change in the liposome particles as a change in membrane disruption of amyloid peptide-GO assemblies.
Experimental Sections

Material
Aβ33-42 (amino acid sequence: NH2-GLMVGGVVIA-COOH) was purchased 
Synthesis of liposome
Firstly, a mixture of 1 g of Lecithin and 0. 
Secondary structural changes measured by circular dichroism spectroscopy
The solution of control Aβ33-42 peptide，as well as the complex solutions with GO concentration at 5μg/mL and 80 μg/mL is characterized by Circular Dichroism (CD). CD measurements were performed on a Spectropolarimeter (PTC-348W1, JASCO, Hachioji City, Japan). The spectral region from 190 nm to 250 nm was scanned with a scan speed of 100 nm/min, with a path length of 0.1 cm and a slit-width of 2 nm. All experiments were carried out at 25°C in a 1-mm quartz cuvette.
For each sample, the baseline, the signal of Milli-Q water, was subtracted from all measurement results. The sample volume for CD measurement is 350 μL. The concentration of control peptide and the one in the complex was both 250 μM.
Raman spectroscopy
Raman measurements were performed by using a laser Raman spectrometer (DXR, Thermo Fisher, USA) at a wavelength of 532 nm. The laser power was set at 10 mW and a 50X objective lens was used to focus the laser beam on the sample. Previously, it has been reported that Aβ33-42 can self-assemble from monomer state to amyloid fibrils in a linear fashion with an exponential growth 46 . Aβ33-42 tends to form β-sheet conformation initially, and gradually assembles into intermediates, and further into fibrils, which follows a typical nucleation-growth process 47 . We obtained the intermediates and mature amyloid fibrils by incubating Aβ33-42 with short time and long time intervals, respectively. Figure.1a and 1d show the AFM images of the intermediates and the fibrils. The intermediates which had been incubated for 1 hour at 37°C were determined to be the amyloid films with the height 3.4 ± 0.8 nm ( Figure.1b and 1c) . Figure 1d shows amyloid fibrils which have been incubated for 6 hours at 37°C. The height of the mature fibrils assembled from Aβ33-42 was measured to be 8.3 ± 2.0 nm ( Figure. 1e), and the histogram distribution was presented in Figure. 1f. The morphology and height distribution of the intermediates and mature fibrils assembled from Aβ33-42 display a clear difference. Graphene oxide is used as the material to modulate assemblies of amyloid peptides. The morphology of GO is characterized by AFM and the height was measured to be ~1 nm (Figure 2a and 2b ). The Raman spectra shows the typical feature of GO ( Figure. 2c) . GO can modulate the assembly of amyloid peptide, which was proved by AFM. In the absence of GO, Aβ33-42 can self-assemble into long and entangled mature fibrils with the height of ~ 8 nm (Figure 2d ). In the presence of GO with the concentration of 5 μg/mL, the short fibrils were observed and also the mature ones existed but with a decreased amount. Meanwhile, flat films were observed (Figure 2e ). When the concentration of GO reached to 80μg/mL, only flat films with uniform height (~1.5 nm) were observed without mature fibrils (Figure 2f ). The morphology difference explored by AFM revealed the modulating effect of GO on self-assembled nanostructures of amyloid peptides, which implied that the large available surface of GO can tune the assembling process of amyloid peptide.
Figure 3
The secondary structure of amyloid peptide characterized by CD spectra. The β-sheet secondary structure was displayed in black line. The secondary structure of amyloid peptide in the presence of GO with the concentration of 5 μg/mL (red line) and 80 μg/mL (blue line).
In addition, we investigated the secondary structure of the amyloid peptide in the presence of GO by CD spectra in Figure 3 . We can easily found that in the absence of GO, the secondary structure of Aβ33-42 is typically β-sheet. However, with increasing amount of GO, from 5 μg/mL to 80 μg/mL, the feature of curve remained the same but with decreased intensity. It is implied that the content of β-sheet of amyloid peptide might decrease in the modulation of GO. The further modulated effect on the interaction between the liposome and the assembled nanostructure of Aβ33-42 modulated by GO were investigated. The summary and the comparison of the size of liposomes were presented in Figure. 6 both in the absence of the peptides/GO and in the presence of the peptides/GO. The clear difference was displayed. It is easy to find that the size of dried liposome decreased with increasing the amount of GO in the modulated assemblies of amyloid peptides. We could deduce that the increment of GO in the modulating assembled nanostructures of amyloid peptides could enhance the ability of membrane interaction. It is certificated by the liposome structure investigation. The exact mechanism of membrane disruption of modulated peptide assembled nanostructures is still unclear. Some possible mechanism was proposed to be the synergistic effect of amyloid peptide aggregate and GO. It is reported that GO are capable of extracting the phospholipid molecules in the previous research 33 . The amyloid peptide could also have the good affinity to the membrane. The modulated structures of amyloid peptides are almost flatten film which is the similar one to the intermediates of peptides that could be relative strong ability to interrupt the membrane. To sum up, the complex of amyloid peptide and GO might have the enhanced ability to the membrane interruption. 
Conclusion
In summary, the modulation effect of GO on the assembled structure of amyloid peptides was explored. The different nanostructures were obtained by tuning the concentration of GO. It is achieved that the membrane disruption of amyloid peptide aggregates could be modulated by GO. With GO's changing concentration we observed small fibrils, aggregates, intermediates and film like assemblies. Their contribution to total toxicity was investigated by lipid membrane disruption study -which was conducted using AFM. We believe our findings would contribute to understanding of amyloid peptide's pathogenesis and toxicity and its environmental effects. They can also be applied to studies where introduction and tuning of the structural control is needed.
